Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report

Intrahepatic cholangiocarcinoma (ICC) arises from the biliary epithelium and is a relatively rare and highly fatal neoplasm. The prognosis is poor, and survival is limited to a few months. Here, we report a case of advanced ICC that was successfully treated with apatinib, a new oral tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Fu-Chao, Yu, Qian, Zeng, Zhi-Ming, He, Rong-Quan, Mo, Chao-Hua, Zhong, Jin-Cai, Ma, Jie, Feng, Zhen-Bo, Chen, Gang, Hu, Xiao-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677377/
https://www.ncbi.nlm.nih.gov/pubmed/29138576
http://dx.doi.org/10.2147/OTT.S146051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677377/
https://www.ncbi.nlm.nih.gov/pubmed/29138576
http://dx.doi.org/10.2147/OTT.S146051

Ejemplares similares